Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 1,946 shares at $290.07 ($564K) on 2017-03-01, disclosed to the SEC on 2017-03-03.
Open-market sale of $564k BIIB by EVP CMO Neuro & Neurodegenerat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.07 | 973 | $282K | 50.0% |
| 2 | $290.07 | 973 | $282K | 50.0% |
| Total | $290.07 avg | 1,946 | $564K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |